A comprehensive assessment of DPM’s medicine regulatory system was conducted September to October 2017 by SIAPS funded by USAID. The WHO Global Benchmarking Tool was used for data collection. The scope of the assessment was focused on the five regulatory functions: national regulatory systems, medicines registration and marketing authorization (MA), pharmacovigilance (PV), market surveillance and control, and clinical trial oversight (CTO).
To better coordinate activities undertaken by all interested stakeholders to control the Ebola outbreak, the Malian government enacted Decision N° 2014-0850/PM-RM of November 14, 2014, resulting in the development of a contingency plan and the establishment of an Emergency Operations Center (EOC). A quantification exercise was conducted with technical assistance and financing from the SIAPS Program for the preparation of consensus-based forecasts, with input from interested stakeholders. This process will facilitate efforts to raise and secure funding for the procurement of needed commodities for the control of Ebola.
Il est important que le SDADME révisé, décrivant le circuit de l’approvisionnement et de la distribution des médicaments essentiels soit connu et mis en œuvre par les acteurs du secteur pharmaceutique. C’est ainsi que la DPM avec l’assistance technique et financière de SIAPS a organisé un atelier de dissémination du SDADME dans les régions de Mopti, Ségou, Koulikoro, Sikasso et Kayes du 15 au 24 juillet 2013.
- The Use of Pharmaceutical Information for Decision Making in Namibia's National ART Program: Assessment Report
SIAPS conducted this assessment to determine the extent to which pharmaceutical information generated from the Electronic Dispensing Tool (EDT) and […]
The Directorate of Drugs and Medical Supplies (DDMS) plays a key role in providing technical guidance and setting strategic direction […]
- Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program Inventory of Key Technical Resources
The main purpose of this inventory is to serve as a reference to help stakeholders working in the pharmaceutical sector […]